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Available online 23 February 2016The human embryonic stem cell line RCe011-A (RC-7) was derived from a failed to fertilise oocyte voluntarily
donated as unsuitable and surplus to fertility requirements following ethics committee approved informed
consent under licence from the UK Human Fertilisation and Embryology Authority. The cell line shows normal
pluripotency marker expression and differentiation to the three germ layers in vitro. It has a normal 46XY
male karyotype and microsatellite PCR identity, HLA and blood group typing data are available.
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RCe011-A (RC-7) was derived from a failed to fertilise oocyte/late
developing embryo that had undergone activation using strontium
chloride (SrCl2)-containing media (Bos-Mikich et al., 1997). As the oo-
cyte resulting in RCe011-A (RC-7) divided shortly after activation, it is
likely to be a late developing embryo rather than oocyte activation, al-
though this has not been veriﬁed. The cell line was derived by whole
embryo outgrowth on mitotically inactivated human ﬁbroblast (HDF)
feeder cells using xeno free medium and expanded under xeno free
and feeder free conditions.
By ﬂow cytometry, RCe011-A (RC-7) expressed the pluripotency
makers Oct 4 and SSEA-4 (87.9% and 99.6%, respectively), whereas low
expression of the differentiation marker SSEA-1 (2.5%) was observed
(Fig. 1, Table 1). Differentiation to the three germ layers, endoderm, ecto-
derm and mesoderm, was demonstrated using embryoid body forma-
tion and expression of the germ layer markers α-fetoprotein, β-tubulin
and muscle actin (Fig. 2).
A microsatellite PCR proﬁle has been obtained for the cell line, and
HLA Class I and II typing is available (Table 2). Blood group genotyping
gave the blood group O1O1 (Table 2).
Veriﬁcation and authentication
The cell line was analysed for genome stability by G-banding (Fig. 3)
and showed a normal 46XY male genotype. The cell line is free from
mycoplasma contamination as determined by RC-qPCR. Microsatellite
PCR DNA proﬁling for cell identity is shown in Table 2.the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. RCe011-A (RC-7) was subjected to ﬂow cytometry analysis for markers of pluripotency with speciﬁc antibody (top row) or isotype control (bottom row) as indicated above the
histograms. Percentage staining is indicated in Table 1.
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Ethics
Derivation of hESC from surplus to requirement and failed to
fertilise/develop embryos and oocytes was approved by The Scotland
A Research Ethics Committee and local ethics board at participating fer-
tility clinics and conducted under licence no R0136 from the UK HFEA
with informed donor consent.Table 1
Summary of quality control testing and results for RCe011-A (RC-7).
Classiﬁcation Test Purpose
Donor screening HIV 1 + 2 Donor scre
Hepatitis B
Hepatitis C
Identity Microsatellite DNA proﬁ
PCR (mPCR)
Phenotype Flow cytometry Assess ant
associated
Genotype
(details provided in Table 2)
Blood group genotyping (DNA analysis) To establis
Karyology (G-banding) Conﬁrmat
HLA tissue typing To establis
Microbiology and virology Mycoplasma Mycoplasm
Endotoxin Screening
Morphology Photography To capture
Differentiation potential Embryoid body formation To show d
Fig. 2. In vitro differentiation of RCe011-A (RC-7) to ectoderm (β-tubulin III), mesoderm (mus
counterstained with DAPI (blue).Cell culture
Failed to fertilise oocyteswere appraised as clinically unusable at the
treatment centre and transferred to Roslin Cells using a portable 37 °C
incubator. They were subjected to an activation regimen consisting
of 10 mM SrCl2 (Sigma-Aldrich, Dorset, UK) in DMEM (ThermoFisher
Scientiﬁc, Paisley, UK) containing 10% v/v HSA (Sigma) for 1 h. All
oocytes were transferred to pre-warmed 30 μl microdrops of Embryo
Assist under parafﬁn oil (both Origio, CooperSurgical, Trumbull, CT,Result
ening for adventitious agents Negative
ling to give cell line its signature, gender/species Performed
igen levels & cell surface markers commonly
with hESC
Oct 3/4: 87.9%
SSEA-4: 99.6%
SSEA-1: 2.5%
h blood group of the line BO1
ion of normal ploidy by G-banding 46XY
h full HLA type I and II genotype of the line HLA typed Class I and Class II
a testing by RT-qPCR Negative
for endotoxin levels 1.73 EU/ml
a visual record of the line Normal
ifferentiation to three germ layers Expression of muscle actin,
β-tubulin and α-feto protein
cle actin), and endoderm (α-fetoprotein). Speciﬁc staining shown in green, cell nuclei are
Table 2
Microsatellite PCR, blood group and HLA tissue typing results for RCe011-A (RC-7).
Microsatellite PCR results
D3S1358 1 D3S1358 2 vWA 1 vWA 2 D16S539 1 D16S539 2 D2S1338 1 D2S1338 2
16 18 15 20 9 10 18 20
Amelogenin 1 Amelogenin 2 D8S1179 1 D8S1179 2 D21S11 1 D21S11 2 D18S51 1 D18S51 2
X Y 11 12 31 32.2 15 18
D19S433 1 D19S433 2 THO1 1 THO1 2 FGA 1 FGA 2 CSF1PO 1 CSF1PO 2
13 13 7 9 21 24 lw* lw*
D5S818 1 D5S818 2 D7S820 1 D7S820 2 D13S317 1 D13S317 2 TPOX 1 TPOX 2
12 12 8.2 13 9 11 8 12
*Peak falls below threshold to conﬁdently score.
Blood group genotyping
RhD RhC Rhc RhE Rhe Fy a Fy b Fy GATA
pos pos pos neg pos pos pos neg
Jka Jkb K k M N S S
pos pos neg pos pos pos pos pos
Kp a Kp b Do a Do b ABO
neg pos neg pos BO1
HLA tissue typing
HLA Class I Type HLA-A*02, A*24; B*27, B*40; C*01, C*02
HLA Class II Type HLA-DRB1*01, DRB1*11; DRB3*02; DQB1*03, DQB1*05
Comment B*40 is expressed serologically as B61, DQB1*03 is expressed serologically as DQ7.
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vated embryos were cultured at 36.5–37.5 °C, 5 ± 0.5% CO2, in drops
under parafﬁn oil (Origio) and transferred to fresh medium at least
every 2–3 days.
By day 8 of development, embryos were placed in derivation condi-
tions consisting of mitotically inactivated neonatal human dermal
ﬁbroblasts (HDFs) (Forticell Biosciences, NJ, USA) on tissue culture
plastic in XF KODMEM medium (Knockout-DMEM, 15% KOSR-XF,
2 mM L-glutamine, 1% MEM Non-essential amino acids, 2% XF Growth
Factor Cocktail, 0.1mMβ-mercaptoethanol, all ThermoFisher Scientiﬁc)
supplemented with 80 ng/ml human bFGF (ThermoFisher Scientiﬁc).
Assisted hatching was performed by removing the zona pellucidae me-
chanically using Swemed Cutting tools (Vitrolife, Göteborg, Sweden).
HDF cells were cultured in DMEM (Lonza, Slough, UK), 10% FCS
(GE Healthcare (PAA), Buckinghamshire, UK) and 2 mM L-glutamine
(ThermoFisher Scientiﬁc). HDFs were mitotically inactivated using
gamma irradiation at 50GY using a Gammacell Elite 1000 machine. For
use as a feeder layer, irradiated HDFs were plated at 50,000 cells/cm2 in
XF KODMEM medium supplemented with 80 ng/ml human bFGF
(ThermoFisher Scientiﬁc). Cells were cultured at 36.5–37.5 °C, 5 ± 0.5%
CO2 and 50% medium exchanged 6 days a week.
The established cell line was expanded and banked using CellStart
matrix and Stempro hESC SerumFreeMedium (ThermoFisher Scientiﬁc).
Passaging was performed mechanically using an EZ passage tool
(ThermoFisher Scientiﬁc). hESC lines were expanded to 25–30 wells
of a 6-well plate and cryopreserved in 0.5–1 ml Cryostor CS10 (Biolife
Solution, Washington, USA).Mycoplasma
Mycoplasma detection was performed using Applied Biosystems
PrepSEQ™ Mycoplasma Nucleic Acid Extraction Kit and MicroSEQ™
Mycoplasma Real-Time PCR Detection Kit (ThermoFisher Scientiﬁc
(Applied Biosystems)) according to manufacturer's instruction.Endotoxin
Endotoxin levels were determined using the Kinetic-QCL assay
(Lonza) and an incubating plate reader (BioTek ELx808) according to
manufacturer's instructions. Brieﬂy, an unknown samplewas compared
with a standard curve of known levels of control endotoxin. An assay
was deemed valid if the coefﬁcient of correlation, r ≥ 0.980 and the
CV (%) for the standard curve was ≤10%.
Flow cytometry
Pluripotency was determined using the Human andMouse Pluripo-
tent Stem Cell Analysis kit (BD, Oxford, UK). Oct3/4 and SSEA-4 were
included as pluripotencymarkers, and SSEA-1 as a differentiationmarker.
Fixed and permeabilised cells were analysed using a FACS Aria ﬂow
cytometer (BD).
In vitro differentiation
Conﬂuent hESCs were lifted using a cell scraper (Corning) and em-
bryoid bodies EBs generated in ultra low attachment plates (Corning)
in EB medium (20% FBS (GE Healthcare (PAA)), 80% KO-DMEM, 1 mM
L-glutamine, 0.1 mM β-mercaptoethanol, 1% nonessential amino acids
(all ThermoFisher Scientiﬁc)). After 9 days in suspension culture, EBs
were being transferred onto glass slide tissue culture chambers (Nunc,
ThermoFisher Scientiﬁc) coated with 0.1% gelatin (Sigma) at 0.1 ml/cm2
and cultured for 14 days.
Immunocytochemistry
hESC were ﬁxed in methanol (ThermoFisher Scientiﬁc), blocked
using 10% goat serum (Sigma) in PBS (Lonza) containing 0.01% Tween-
20 (Sigma) and stained with AFP (1:500; Sigma), β-tubulin III (1:1000;
Sigma), muscle-speciﬁc actin (1:50; DAKO, Glostrup, Denmark), and
Fig. 3. RCe011-A (RC-7) was analysed by Giesma staining of 20 metaphase spreads and showed a normal 46XY male karyotype.
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Scientiﬁc). Images were acquired using a Zeiss S100 Axiovert ﬂuores-
cence microscope or Nikon eC1 confocal microscope.
Genomic analysis
All outsourced assayswere carried out under a Quality and Technical
Agreement. DNA was extracted using the QIAamp DNA Mini kit
(Qiagen, Manchester, UK) according to manufacturer's recommenda-
tions and provided in recommended quantities to the service providers.
Microsatellite PCR, or Short Tandem Repeat analysis, was used to
determine cell line identity and was carried out by Public Health
England. A proﬁle was obtained for the following core alleles: vWA,
D16S539, Amelogenin, THO1, CSF1PO, D5S818, D75820, D135317 and
TPOX.
Human Leukocyte Antigen (HLA) tissue typing was carried out by
the Scottish National Blood Transfusion Service.
Blood group genotyping was carried out by the Molecular Diagnos-
tics laboratory at NHSBT.
Karyotype analysis was carried out by The Doctors Laboratory
(London, UK) or the Western General Cytogenetics Laboratory(Edinburgh, UK) Live cells at 60–70% conﬂuencywere shipped overnight
in warm containers, ﬁxed and analysed by standard G-banding analysis.
For research grade lines, 20 spreads were analysed.
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